Recombinant Human CD161 Fc Chimera Protein, CF
R&D Systems, part of Bio-Techne | Catalog # 7448-CD
Key Product Details
Product Specifications
Source
Chinese Hamster Ovary cell line, CHO-derived human CD161 protein
Met-Asp | Human IgG1 (Pro100-Lys330) |
IEGR | Human CD161 (Lys68-Ser225) Accession # Q12918 |
N-terminus | C-terminus |
Purity
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Level
<0.01 EU per 1 μg of the protein by the LAL method.
N-terminal Sequence Analysis
Met-Asp
Predicted Molecular Mass
45 kDa
SDS-PAGE
58-70 kDa, reducing conditions
Activity
Measured by its binding ability in a functional ELISA.
When Recombinant Human CD161 Fc Chimera is coated at 5 μg/mL (100 μL/well), the concentration of recombinant human CLEC-2A Fc Chimera that produces 50% optimal binding response is found to be approximately 2-10 μg/mL.
When Recombinant Human CD161 Fc Chimera is coated at 5 μg/mL (100 μL/well), the concentration of recombinant human CLEC-2A Fc Chimera that produces 50% optimal binding response is found to be approximately 2-10 μg/mL.
Formulation, Preparation and Storage
7448-CD
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution |
Reconstitute at 100 μg/mL in PBS.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Background: CD161
References
- Mesci, A. et al. (2006) Immunol. Res. 35:13.
- Carlyle, J.R. et al. (2008) Semin. Immunol. 20:321.
- Lanier, L.L. et al. (1994) J. Immunol. 153:2417.
- Poggi, A. et al. (1996) Eur. J. Immunol. 26:1266.
- Pandya, A.D. et al. (2011) PLos ONE 6:e26780.
- Turtle, C.J. et al. (2011) Blood 118:2752.
- Balato, A. et al. (2009) J. Invest. Dermatol. 129:1628.
- Maggi, L. et al. (2010) Eur. J. Immunol. 40:2174.
- Mjosberg, J.M. et al. (2011) Nat. Immunol. 12:1055.
- Bennett, I.M. et al. (1996) J. Exp. Med. 184:1845.
- Poggi, A. et al. (1998) Eur. J. Immunol. 28:1611.
- Azzoni, L. et al. (1998) J. Immunol. 161:3493.
- Annunziato, F. et al. (2008) Int, Immunol. 11:1361.
- Billerbeck, E. et al. (2010) Proc. Natl. Acad. Sci. USA 107:3006.
- Poggi, A. et al. (1997) Eur. J. Immunol. 27:2965.
- Germain, C. et al. (2011) J. Biol. Chem. 286:37964.
- SwissProt Accession # Q12918.
- Rosen, D.B. et al. (2008) 180:6508.
- Pozo, D. et al. (2006) J. Immunol. 176:2397.
- Cosmi, L. et al. (2008) J. Exp. Med. 205:1903.
- Kamishikiryo, J. et al. (2011) J. Biol. Chem. 286:23823.
- Aldemir, H. et al. (2005) J. Immunol. 176:7791.
- Rosen, D.B. et al. (2005) J. Immunol. 176:7796.
- Huarte, E. et al. (2008) Blood 112:1259.
- Germain, C. et al. (2010) J. Biol. Chem. 285:36207.
- Bambard, N.D. et al. (2010) Scand. J. Immunol. 71:210.
Alternate Names
CD161, CLEC5B, KLRB1, Ly59, NKR, NKRP1, NKRP1A
Gene Symbol
KLRB1
UniProt
Additional CD161 Products
Product Documents for Recombinant Human CD161 Fc Chimera Protein, CF
Product Specific Notices for Recombinant Human CD161 Fc Chimera Protein, CF
For research use only
Loading...
Loading...
Loading...